Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is G  [Clear All Filters]
2020
Ge N, Liu M, Zhu X, Krawczyk J, McInerney V, Shen S, O'Brien T, Prendiville T. Generation and characterization of two induced pluripotent stem cell lines (NUIGi038-A, NUIGi038-B) from dermal fibroblasts of a healthy individual. Stem Cell Res. 2020;49:101996.
Luo Y, Frischbutter S, Scheffel J, Siebenhaar F. Generation and Culture of Peripheral CD34 Stem Cell-Derived Mast Cells (PSCMCs). Methods Mol Biol. 2020;2163:63-67.
Bouma MJ, Orlova V, van den Hil FE, Mager H-J, Baas F, de Knijff P, Mummery CL, Mikkers H, Freund C. Generation and genetic repair of 2 iPSC clones from a patient bearing a heterozygous c.1120del18 mutation in the ACVRL1 gene leading to Hereditary Hemorrhagic Telangiectasia (HHT) type 2. Stem Cell Res. 2020;46:101786.
Nakatake Y, Ko SBH, Sharov AA, Wakabayashi S, Murakami M, Sakota M, Chikazawa N, Ookura C, Sato S, Ito N, et al. Generation and Profiling of 2,135 Human ESC Lines for the Systematic Analyses of Cell States Perturbed by Inducing Single Transcription Factors. Cell Rep. 2020;31(7):107655.
Sripathy SR, Wang Y, Moses RL, Fatemi A, Batista DA, Maher BJ. Generation of 10 patient-specific induced pluripotent stem cells (iPSCs) to model Pitt-Hopkins Syndrome. Stem Cell Res. 2020;48:102001.
Leavens KF, Liao C-M, Gagne AL, Kishore S, Cardenas-Diaz FL, French DL, Gadue P. Generation of a double insulin and somatostatin reporter line, SCSe001-A-3, for the advancement of stem cell-derived pancreatic islets. Stem Cell Res. 2020;50:102112.
Zhang T, Huang W, Xue X. Generation of a FOXH1 homozygous knockout human embryonic stem cell line by CRISPR/Cas9 system. Stem Cell Res. 2020;50:102121.
Liu C-L, Huang C-Y, Chen H-C, Lu H-E, Hsieh PCH, Lee J-J. Generation of a gene corrected human isogenic IBMS-iPSC-014-C from polycystic-kidney-disease induced pluripotent stem cell line using CRISPR/Cas9. Stem Cell Res. 2020;45:101784.
Fulgencio-Covián A, Álvarez M, Pepers BA, López-Márquez A, Ugarte M, Pérez B, van Roon-Mom WMC, Desviat LR, Richard E. Generation of a gene-corrected human isogenic line (UAMi006-A) from propionic acidemia patient iPSC with an homozygous mutation in the PCCB gene using CRISPR/Cas9 technology. Stem Cell Res. 2020;49:102055.
Lilianty J, Patria YNur, Stanley EG, Elefanty AG, Bateman JF, Lamandé SR. Generation of a heterozygous COL2A1 (p.R989C) spondyloepiphyseal dysplasia congenita mutation iPSC line, MCRIi001-B, using CRISPR/Cas9 gene editing. Stem Cell Res. 2020;45:101843.
Siehler J, Blöchinger AKarolina, Akgün M, Wang X, Shahryari A, Geerlof A, Lickert H, Burtscher I. Generation of a heterozygous C-peptide-mCherry reporter human iPSC line (HMGUi001-A-8). Stem Cell Res. 2020;50:102126.
Li X, Liu Y, Liu F, Wang X, Liu M, Du W, Zhao J, Wang M, Hu L, Wang C, et al. Generation of a hiPSC line ZZUNEUi007-A from a patient with hypertrophic cardiomyopathy caused by mutation in MYH7. Stem Cell Res. 2020;43:101699.
Wang M, Ruan Y, Tian X, Liu Y, Liu M, Fu W, Du W, Zhao J, Hu L, Li X, et al. Generation of a hiPSC line ZZUNEUi012-A from a healthy female individual. Stem Cell Res. 2020;50:102143.
Moya N, Shahryari A, Burtscher I, Beckenbauer J, Bakhti M, Lickert H. Generation of a homozygous ARX nuclear CFP (ARX) reporter human iPSC line (HMGUi001-A-4). Stem Cell Res. 2020;46:101874.
Tang X, Chen Z, Tan X, Luo L, Liu X, Gong L, Li DWan-Cheng, Liu Y. Generation of a homozygous CRISPR/Cas9-mediated knockout H9 hESC subline for the CRB1 locus. Stem Cell Res. 2020;49:102057.
Wu X, Zhao Y, Wang X. Generation of a human embryonic stem cell line (WAe009-A-43) carrying a Long QT syndrome related mutation in KCNH2 gene. Stem Cell Res. 2020;48:101976.
Quan Y, Zhang T, Zhang H, Yang J, Jin P, Ma J, Fan Y, Fan J, Fan X, Gong Y, et al. Generation of a human embryonic stem cell (WAe001-A-47) with hVGLL4 doxycyclin-inducible expression by the PiggyBac transposon system. Stem Cell Res. 2020;50:102142.
Ou-Yang C-H, Lin H-Y, Huang C-Y, Lin C-H. Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-057-05) from a patient with familial parkinsonism and polyneuropathy having a heterozygous p.Y314S mutation in UQCRC1 gene. Stem Cell Res. 2020;49:102031.
Kamata K, Otsuka Y, Imamura K, Oishi A, Kondo T, Suga M, Shibukawa R, Okanishi Y, Sagara Y, Tsukita K, et al. Generation of a human induced pluripotent stem cell line, BRCi004-A, derived from a patient with age-related macular degeneration. Stem Cell Res. 2020;45:101787.
Kamata K, Otsuka Y, Imamura K, Oishi A, Kondo T, Suga M, Shibukawa R, Okanishi Y, Sagara Y, Tsukita K, et al. Generation of a human induced pluripotent stem cell line, BRCi005-A, derived from a Best disease patient with BEST1 mutations. Stem Cell Res. 2020;45:101782.
Katagami Y, Kondo T, Suga M, Yada Y, Imamura K, Shibukawa R, Sagara Y, Okanishi Y, Tsukita K, Hirayama K, et al. Generation of a human induced pluripotent stem cell line, BRCi009-A, derived from a patient with glycogen storage disease type 1a. Stem Cell Res. 2020;49:102095.
Na DHyun, Lim SWoo, Kim B-M, Kim KWoon, Shin YJin, Chae H, Ko EJeong, Yang CWoo, Kim M, Chung BHa. Generation of a human induced pluripotent stem cell line (CMCi001-A) from a patient with karyomegalic interstitial nephritis with homozygous frameshift deletion mutation c.1985_1994del10 of the FANCD2/FANCI-Associated Nuclease 1 gene. Stem Cell Res. 2020;46:101876.
Wang H, Wu K, Guan J, Wang Q. Generation of a human induced pluripotent stem cell line (CPGHi001-A) from a hearing loss patient with the TMC1 p.M418K mutation. Stem Cell Res. 2020;49:101982.
Suzuki H, Egawa N, Kondo T, Imamura K, Enami T, Tsukita K, Suga M, Shibukawa R, Okanishi Y, Uchiyama T, et al. Generation of a human induced pluripotent stem cell line derived from a Parkinson's disease patient carrying SNCA duplication. Stem Cell Res. 2020;45:101828.
Park H, Han J, Lee Y, Kwak S, Koo SKyung. Generation of a human induced pluripotent stem cell line from a patient with Leber congenital amaurosis. Stem Cell Res. 2020;43:101725.

Pages